Valuation (33%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.41 | N/A |
PEG Ratio (TTM) | 0.49 | N/A |
P/S Ratio (TTM) | 4.33 | N/A |
P/B Ratio (TTM) | 0.27 | N/A |
P/FCF Ratio (TTM) | -0.49 | N/A |
Price to 5YR AVG Earnings Ratio | -0.45 | N/A |
Price to 5YR AVG FCF Ratio | -0.47 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -55.96% | N/A |
ROE (TTM) | -53.86% | N/A |
Net Profit Margin (TTM) | -1,047.12% | N/A |
ROIC 5YR AVG | -93.16% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.22% | -2.66% | -0.50% |
Revenue | -25.00% | N/A | N/A |
Net Income | -0.70% | -45.30% | -27.21% |
Cash Flow | -6.57% | -53.53% | -34.32% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 8.84 | N/A |
Quick Ratio (TTM) | 8.84 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -312.33 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.14 | N/A |
Shares Outstanding Growth 5YR AVG | 835.37% | N/A |